These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 1334349)

  • 21. Kininase-independent potentiation of endothelium-dependent relaxations to kinins by converting enzyme inhibitor perindoprilat.
    Mombouli JV; Ballard KD; Vanhoutte PM
    Acta Pharmacol Sin; 2002 Mar; 23(3):203-7. PubMed ID: 11918842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Converting-enzyme inhibitors potentiate bradykinin-induced relaxation in vitro.
    Félétou M; Germain M; Teisseire B
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H839-45. PubMed ID: 1558194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin-(1-7) augments endothelium-dependent relaxations of porcine coronary arteries to bradykinin by inhibiting angiotensin-converting enzyme 1.
    Raffai G; Khang G; Vanhoutte PM
    J Cardiovasc Pharmacol; 2014 May; 63(5):453-60. PubMed ID: 24390175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potentiation by trandolaprilat of the endothelium-dependent hyperpolarization induced by bradykinin.
    Illiano S; Mombouli JV; Nagao T; Vanhoutte PM
    J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S6-10. PubMed ID: 7527103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of bradykinin on coronary flow and its potentiation by SH-containing ACE-inhibitors.
    de Graeff PA; van Gilst WH
    Agents Actions Suppl; 1992; 38 ( Pt 3)():110-8. PubMed ID: 1462853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Panax ginseng extract (G115) on angiotensin-converting enzyme (ACE) activity and nitric oxide (NO) production.
    Persson IA; Dong L; Persson K
    J Ethnopharmacol; 2006 May; 105(3):321-5. PubMed ID: 16387458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of angiotensin-converting enzyme in human hand veins.
    Chalon S; Bedarida GV; Moreno H; Tejura B; Urae A; Hoffman BB; Blaschke TF
    Clin Pharmacol Ther; 1999 Jan; 65(1):58-65. PubMed ID: 9951431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibroblast growth factor-2 mediates Angiotensin-converting enzyme inhibitor-induced angiogenesis in coronary endothelium.
    Donnini S; Solito R; Giachetti A; Granger HJ; Ziche M; Morbidelli L
    J Pharmacol Exp Ther; 2006 Nov; 319(2):515-22. PubMed ID: 16868034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ACE inhibitor effect on bradykinin metabolism in the vascular wall.
    Gohlke P; Bünning P; Bönner G; Unger T
    Agents Actions Suppl; 1992; 38 ( Pt 3)():178-85. PubMed ID: 1462857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bradykinin-induced relaxation of coronary microarteries: S-nitrosothiols as EDHF?
    Batenburg WW; Popp R; Fleming I; de Vries R; Garrelds IM; Saxena PR; Danser AH
    Br J Pharmacol; 2004 May; 142(1):125-35. PubMed ID: 15066907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Femtomolar bradykinin-induced relaxation of isolated bovine coronary arteries, mediated by endothelium-derived nitric oxide.
    Nakamura Y; Kawagoe K; Obi T; Miyamoto A; Ishiguro S; Nishio A
    J Vet Pharmacol Ther; 1998 Aug; 21(4):304-8. PubMed ID: 9731953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinin-mediated coronary nitric oxide production contributes to the therapeutic action of angiotensin-converting enzyme and neutral endopeptidase inhibitors and amlodipine in the treatment in heart failure.
    Zhang X; Recchia FA; Bernstein R; Xu X; Nasjletti A; Hintze TH
    J Pharmacol Exp Ther; 1999 Feb; 288(2):742-51. PubMed ID: 9918584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of ACE inhibition on endothelial dysfunction in patients with chronic heart failure.
    Hornig B; Arakawa N; Drexler H
    Eur Heart J; 1998 Jul; 19 Suppl G():G48-53. PubMed ID: 9717056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relaxation of isolated coronary arteries by angiotensin-converting enzyme inhibitors: role of endothelium-derived kinins.
    Hecker M; Bara AT; Busse R
    J Vasc Res; 1993; 30(5):257-62. PubMed ID: 8399986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level.
    Hecker M; Pörsti I; Bara AT; Busse R
    Br J Pharmacol; 1994 Jan; 111(1):238-44. PubMed ID: 8012702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal flow-mediated epicardial vasomotion in human coronary arteries is improved by angiotensin-converting enzyme inhibition: a potential role of bradykinin.
    Prasad A; Husain S; Quyyumi AA
    J Am Coll Cardiol; 1999 Mar; 33(3):796-804. PubMed ID: 10080484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of angiotensin II type 1 receptor antagonism on endothelial function: role of bradykinin and nitric oxide.
    Landmesser U; Drexler H
    J Hypertens Suppl; 2006 Mar; 24(1):S39-43. PubMed ID: 16601572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of angiotensin-converting-enzyme inhibition on bradykinin metabolism by vascular endothelial cells.
    Gräfe M; Bossaller C; Graf K; Auch-Schwelk W; Baumgarten CR; Hildebrandt A; Fleck E
    Am J Physiol; 1993 May; 264(5 Pt 2):H1493-7. PubMed ID: 8388656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of the angiotensin converting enzyme by perindoprilat and release of nitric oxide.
    Desta B; Vanhoutte PM; Boulanger CM
    Am J Hypertens; 1995 May; 8(5 Pt 2):1S-6S. PubMed ID: 7544135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelium-dependent relaxation by angiotensin-converting enzyme inhibitors in canine femoral arteries.
    Moroi M; Akatsuka N; Fukazawa M; Hara K; Ishikawa M; Aikawa J; Namiki A; Yamaguchi T
    Am J Physiol; 1994 Feb; 266(2 Pt 2):H583-9. PubMed ID: 8141360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.